Borane N,N-diethylaniline complex

• Catalog No.: 179043
• CAS Number: 13289-97-9
• M. F.: C10H18BN
• M. W.: 163.06762

SYNONYMS

• Title: 硼烷-N,N-二乙基苯胺络合物
• IUPAC name: N,N-diethylaniline borane
• IUPAC Traditional name: N,N-diethylaniline borane
• Synonyms: (N,N-Diethylaniline)trihydroboron; Diethylphenylamine-borane; NSC 239123

DATABASE IDS

• MDL Number: MFCD00013187
• EC Number: 236-305-2
• PubChem SID: 24850794
• CAS Number: 13289-97-9

PROPERTIES

• Risk Statements: 10-14
• Safety Statements: 16-33-36/37/39-43
• Supplemental Hazard Statements: Reacts violently with water.
• Hazard Class: 4.3
• UN Number: 3398
• Packing Group: 2
• German water hazard class: 3
• GHS Signal Word: Danger
• GHS Hazard statements: H225-H261
• Personal Protective Equipment: Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
• GHS Precautionary statements: P210-P231 + P232-P422
• RID/ADR: UN 3398 4.3/PG 2
• Linear Formula: C6H5N(C2H5)2·BH3
• Density: 0.917 g/mL at 25 °C(lit.)
• Flash Point: 21 °C
• Flash Point: 69.8 °F
• Melting Point: -30--27 °C(lit.)

DETAILS

Description (English)

Packaging
25, 100 g in Sure/Seal™
Application
Reactant for:
• Diastereoselective reduction of prochiral enone intermediates1
• Borylation of aryl halides2
• Reductions of ketones, acids, esters, amides, and nitriles3
• Investigations of borane source on enantioselectivity in enantiopure oxazaborolidine-catalyzed asymmetric borane reduction of ketones4Reactant for synthesis of:
• Chromanol derivatives as CETP inhibitors for the treatment of cardiovascular disease5
• Allylic alcohols via enantioselective reductions6
• Pinacolboranes for one-pot synthesis of unsymmetrical biaryls7

Description (简体中文)

包装
25, 100 g in Sure/Seal™
Application
Reactant for:
• Diastereoselective reduction of prochiral enone intermediates1
• Borylation of aryl halides2
• Reductions of ketones, acids, esters, amides, and nitriles3
• Investigations of borane source on enantioselectivity in enantiopure oxazaborolidine-catalyzed asymmetric borane reduction of ketones4Reactant for synthesis of:
• Chromanol derivatives as CETP inhibitors for the treatment of cardiovascular disease5
• Allylic alcohols via enantioselective reductions6
• Pinacolboranes for one-pot synthesis of unsymmetrical biaryls7